Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-05-02
2010-06-22
Shibuya, Mark L (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S040520
Reexamination Certificate
active
07741052
ABSTRACT:
A method for aiding in the determination of whether a living or deceased human is afflicted with or will likely have atherosclerosis respectfully, the method comprising determining the level of SPRR3 protein in a intimae or body fluid sample by using molecular localization analysis technique comparing the determined level of SPRR3 protein in the biological sample obtained from said individual with a range of SPRR3 levels previously defined as characteristic for humans having atherosclerosis, concluding from the comparison that the person is likely suffering from atherosclerosis when a SPRR3 level is in the range previously defined as characteristic for the presence of atherosclerosis as an indication that the individual is suffering from or has suffered from atherosclerosis.
REFERENCES:
Steinert et al., “Transglutaminase crosslinking and structural studies of the human small proline rich 3 protein” (1999) Cell Death and Differentiation (1999) 6, 916-930.
Cabral et al. “Structural Organization and Regulation of the Small Proline-rich Family of Cornified Envelope Precursors Suggest a Role in Adaptive Barrier Function” J Biol Chem. Jun. 1, 2001; 276(22):19231-7.
Burtis, C.A. (Ed.), Tietz Textbook of Clinical Chemistry, 3rd Edition, (1999), W.B. Saunders Company, Philadelphia, PA, p. 477.
Information Hyperlinked Over Proteins (iHOP), entry information for Sprr3 and SPRR3, retrieved from http://www.ihop-net.org/UniPub/iHOP/mgi/124857.html and from http://www.ihop-net.org/UniPub/iHOP/gs/92372.html, respectively, on Jun. 10, 2009 (2 pages total).
“EST70772”, retrieved from http://www.ncbi.nlm.nih.gov/entrez/viewerfcgi?db=protein&val=2013806 on Nov. 9, 2009 (2 pages).
“Homo sapiens small proline —rich protein 3 (SPRR3)”, retrieved from http://www.ncbi.nlm.nih.gov/entrez/viewerfcgi?db=nucleotide&val=4885606 on Nov. 9, 2009 (4 pages).
“Chapter 2: Histochemistry— Introduction”, retrieved from http://homepages.gac.edu/˜cellab/chpts/chpt2/intro2.html. On Jan. 19, 2010 (6 pages).
Monoclonal Antibody Production, a Report of the Committee on Methods of Producing Monoclonal Antibodies Institute for Laboratory Animal Research National Research council, National Academy Press, Washington DC 1999.
“Clinical Laboratory Methods for Detection of Antigens & Antibodies”, Basic and Clinical Immunology (Stites & Terr eds.,) 7th ed. 1991., Chapter 18, pp. 217-262.
“Enzyme-Linked Immunosorbent Assay (ELISA)”, Chapter 8 in: Clark et al., Enzyme Immunoassay (Maggio, ed., 1980), pp. 167-179.
“Strategies for Cloning in Plasmic Vectors”, Sambrook et al., 1989, Molecular Cloning, A Laboratory Manual, Cold Spring Harbor Press, N.Y., pp. 1.53-1.73.
Wolff et al., PNAS 86:9011-9014 (1989).
Rosenberg et al., Science 242:1575-1578 (1988).
Caplen et al., Nature Med., 1:39-46 (1995).
Zhu et al., Science, 261:209-211 (1993).
Stehbens WE: Structural and architectural changes during arterial development and the role of hemodynamics. Acta Anat 1996, 157:261-274.
Mills I, Sumpio BE: Vascular smooth muscle cells. Armonk, New York, Futura Publishing Company, Inc., 1997, pp. 187-226.
Fry DL: Arterial intimal-medial permeability and coevolving structural responses to defined shear-stress exposures. Am J Physiol Heart Circ Physiol 2002, 283:H2341-H2355.
Schwartz SM, Majesky MW, Murry CE: The intima: development and monoclonal responses to injury. Atherosclerosis 1995, 118:S125-S140.
Cleaver O, Melton DA: Endothelial signaling during development. Nature Med 2003, 9:661-668.
Carmeliet P: Angiogenesis in health and disease. Nature Med 2003, 9:653-660.
Curto EV, Lambert GW, Davis RL, Wilborn TW, Dooley TP: Biomarkers of human skin cells identified using dermarray DNA arrays and new bioinformatics methods. Biochem Biophys Res Comm 2002, 291:1052-1064.
Marenholz I, Zirra M, Fischer DF, Backendort C, Ziegler A, Mischke D: Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library. Genome Res 2001, 11:341-355.
Kalinin AE, Kajava AV, Steinert PM: Epithelial barrier function: assembly and structural features of the cornified cell envelope. BioEssays 2002, 24:789-800.
Gibbs S, Funeman R, Wiegant J, Geurts van Kessel A, Putte P, Backendorf C: Molecular characterization and evolution of the SPRR family of keratinocyte differentiation markers encoding small proline-rich proteins. Genomics 1993, 16:630-637.
Jamik M, Kartasove T, Steinert PM, Lichti U, Steven AC: Differential expression and cell envelope incorporation of small proline-rich protein 1 in different comified epithelia. J Cell Science 1996, 109:1381-1391.
Nemes Z, Steinert PM: Bricks and mortar of the epidermal barrier. Exp Mol Med 1999, 31:5-19.
Bonilla IE, Tanabe K, Strittmatter SM: Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J Neuroscience 2002, 22:1303-1315.
Champliaud M, Baden HP, Koch M, Jin W, Burgeson RE, Viel A: Gene characterization of sciellin (SCEL) and protein localization in vertebrate epithelia displaying barrier properties. Genomics 2000, 70:264-268.
Baden HP, Kvedar JC: Epithelial cornified envelope precursors are in the hair follicle. J Invest Dermatol 1993, 101:72S-74S.
Kwei S, Stavrakis G, Takahas M, Taylor G, Folkman MJ, Gimbrone MA, Garcia-Cardena G: Early adaptive responses of the vascular wall during venous arterialization in mice. Am J Pathol 2004, 164:81-89.
Karashima T, Watt FM: Interaction of periplakin and envoplakin with intermediate filaments. J Cell Science 2002, 115:5027-5037.
Fuchs E, Weber K: Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem 1994, 63:345-382.
Waseem A, Alam Y, Dogan B, White KN, Leigh IM, Waseem NH: Isolation, sequence and expression of the gene encoding human keratin 13. Gene 1998, 215:269-279.
Johansson B, Eriksson A, Thornell L: Intermediate filament proteins in developing human arteries. Anat Embryol 1999, 199:225-231.
Marshall D, Hardman MJ, Nield KM, Byrne C: Differentially expressed late constituents of the epidermal cornified envelope. Proc Natl Acad Sci, USA 2001, 98:13031-13036.
North AJ, Bardsley WG, Hyam J, Bornslaeger EA, Cordingley HC, Trinnaman B, Hatzfeld M, Green KJ, Magee AI, Garrod DR: Molecular map of the desmosomal plaque. J Cell Science 1999, 4325-4336.
Vestweber D: Molecular mechanisms that control endothelial cell contacts. J Pathol 2000, 190:281-291.
Gallicano GI, Bauer C, Fuchs E: Rescuing desmoplatkin function in extra-embryonic ectoderm reveals the importance of this protein in embryonic heart, neuroepithelium, skin and vasculature. Development 2001, 128:929-941.
Schnittler HJ, Puschel B, Drenchkhahn D: Role of cadherins and plakoglobin in interendothelial adhesion under resting conditions and shear stress. Am J Physiol Heart Circ Physiol 1997, 273:H23296-H22405.
Troyanovsky RB, Chitaev NA, Troyanovsky SM: Cadherin binding sites of plakoglobin: localization, specificity and role in targeting to adhering junctions. J. Cell Science 1996, 109:3069-3078.
Hoffmann I, Mertens C, Brettel M, Nimmrich V, Schnolzer M, Herrmann H: Interaction of plakophilins with desmoplakin and intermediate filament proteins: an in vitro analysis. J Cell Science 2000, 113:2471-2483.
Magnaldo T, Darmon M: Galectin-7, a new marker of mammalian stratified epithelia. Trends Glycoscience Glycotechnology 1997, 9:95-102.
Timmons PM, Colnot C, Cail I, Poirier F, Magnaldo T: Expression of galectin-7 during epitelial development coincides with the onset of stratification. Int J Dev Diol 1999, 43:229-235.
Haroon Z, Wannenburg T, Gupta M, Greenberg CS, Wallin R, Sane DC: Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression. Lab Invest 2001, 81:83-93.
Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM, McDonald DM, Yancopoulos GD: Ephrin-B2 selectively marks arterial vessels and neovascularization sites in t
Ladenson Jack H.
Modur Vijay
Young Pampee P.
Armstrong Teasdale LLP
Foster Christine
Shibuya Mark L
Washington University in St. Louis
LandOfFree
Method of assessing the risk of atherosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of assessing the risk of atherosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of assessing the risk of atherosclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4178769